In humans, 50-60% AChE inhibition produces mild symptoms, 60-90% inhibition produces moderate symptoms, and >90% inhibition causes death due to respiratory or heart failure (Lionetto et al., 2013). The gene discussed is ACHE; the disease is heart failure.